nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—coronary artery disease	0.581	1	CbGaD
Hydralazine—RYR2—sinoatrial node—coronary artery disease	0.0361	0.546	CbGeAlD
Hydralazine—CYP3A4—Ticagrelor—coronary artery disease	0.0238	0.146	CbGbCtD
Hydralazine—CYP3A4—Fenofibrate—coronary artery disease	0.0213	0.13	CbGbCtD
Hydralazine—CYP3A4—Gemfibrozil—coronary artery disease	0.017	0.104	CbGbCtD
Hydralazine—CYP3A4—Clopidogrel—coronary artery disease	0.0147	0.0904	CbGbCtD
Hydralazine—CYP3A4—Eplerenone—coronary artery disease	0.0137	0.0841	CbGbCtD
Hydralazine—CYP3A4—Enalapril—coronary artery disease	0.0122	0.0749	CbGbCtD
Hydralazine—CYP3A4—Rosuvastatin—coronary artery disease	0.00949	0.0583	CbGbCtD
Hydralazine—CYP3A4—Ezetimibe—coronary artery disease	0.00949	0.0583	CbGbCtD
Hydralazine—CYP3A4—Simvastatin—coronary artery disease	0.00882	0.0542	CbGbCtD
Hydralazine—CYP3A4—Pravastatin—coronary artery disease	0.00864	0.053	CbGbCtD
Hydralazine—CYP3A4—Lovastatin—coronary artery disease	0.00864	0.053	CbGbCtD
Hydralazine—CYP3A4—Atorvastatin—coronary artery disease	0.00787	0.0483	CbGbCtD
Hydralazine—CYP3A4—Losartan—coronary artery disease	0.00719	0.0442	CbGbCtD
Hydralazine—RYR2—cardiac ventricle—coronary artery disease	0.00321	0.0485	CbGeAlD
Hydralazine—RYR2—myocardium—coronary artery disease	0.00302	0.0456	CbGeAlD
Hydralazine—AOC3—endothelium—coronary artery disease	0.00291	0.0439	CbGeAlD
Hydralazine—RYR2—heart—coronary artery disease	0.00211	0.0318	CbGeAlD
Hydralazine—RYR2—cardiovascular system—coronary artery disease	0.00199	0.03	CbGeAlD
Hydralazine—AOC3—cardiac ventricle—coronary artery disease	0.00193	0.0292	CbGeAlD
Hydralazine—AOC3—myocardium—coronary artery disease	0.00182	0.0274	CbGeAlD
Hydralazine—RYR2—cardiac atrium—coronary artery disease	0.0018	0.0272	CbGeAlD
Hydralazine—P4HA1—cardiac ventricle—coronary artery disease	0.00154	0.0233	CbGeAlD
Hydralazine—P4HA1—myocardium—coronary artery disease	0.00145	0.0219	CbGeAlD
Hydralazine—AOC3—heart—coronary artery disease	0.00127	0.0192	CbGeAlD
Hydralazine—AOC3—cardiovascular system—coronary artery disease	0.0012	0.0181	CbGeAlD
Hydralazine—AOC3—cardiac atrium—coronary artery disease	0.00108	0.0164	CbGeAlD
Hydralazine—P4HA1—heart—coronary artery disease	0.00101	0.0153	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.000959	0.0186	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.000959	0.0186	CbGpPWpGaD
Hydralazine—P4HA1—cardiovascular system—coronary artery disease	0.000957	0.0145	CbGeAlD
Hydralazine—AOC3—blood—coronary artery disease	0.000946	0.0143	CbGeAlD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—MYL2—coronary artery disease	0.000928	0.018	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GUCY1A3—coronary artery disease	0.000896	0.0174	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CDH2—coronary artery disease	0.000874	0.017	CbGpPWpGaD
Hydralazine—P4HA1—cardiac atrium—coronary artery disease	0.000867	0.0131	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PLN—coronary artery disease	0.000846	0.0164	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ATP2A2—coronary artery disease	0.000829	0.0161	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTB—coronary artery disease	0.000818	0.0159	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—RAMP2—coronary artery disease	0.000799	0.0155	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.000794	0.0154	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—PLN—coronary artery disease	0.000791	0.0154	CbGpPWpGaD
Hydralazine—P4HA1—blood—coronary artery disease	0.000757	0.0114	CbGeAlD
Hydralazine—RYR2—Ion channel transport—ATP4A—coronary artery disease	0.000705	0.0137	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000676	0.0131	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ATP2B1—coronary artery disease	0.000669	0.013	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—ATP2B1—coronary artery disease	0.000625	0.0122	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGAV—coronary artery disease	0.00062	0.0121	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—SLC8A1—coronary artery disease	0.000617	0.012	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—SLC8A1—coronary artery disease	0.000598	0.0116	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—coronary artery disease	0.000594	0.0116	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000588	0.0114	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PLCB3—coronary artery disease	0.000577	0.0112	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PLCB3—coronary artery disease	0.000559	0.0109	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000556	0.0108	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.00054	0.0105	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ADM—coronary artery disease	0.000528	0.0103	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PDE4B—coronary artery disease	0.000515	0.01	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000496	0.00964	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB3—coronary artery disease	0.000488	0.0095	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ATP2A2—coronary artery disease	0.000473	0.0092	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IGFBP3—coronary artery disease	0.000459	0.00892	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ATP2A2—coronary artery disease	0.000459	0.00892	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ACTB—coronary artery disease	0.000453	0.00881	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CAMK2D—coronary artery disease	0.000444	0.00864	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—ATP2A2—coronary artery disease	0.000443	0.00861	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CAMK2D—coronary artery disease	0.00043	0.00837	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB1—coronary artery disease	0.000411	0.00799	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CALR—coronary artery disease	0.000409	0.00796	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000397	0.00772	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000396	0.00771	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000367	0.00714	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000354	0.00688	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000354	0.00688	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GJA1—coronary artery disease	0.000339	0.0066	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000338	0.00657	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB2—coronary artery disease	0.000333	0.00648	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCE—coronary artery disease	0.000329	0.0064	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GJA1—coronary artery disease	0.000329	0.00639	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000327	0.00636	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCE—coronary artery disease	0.000319	0.0062	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000306	0.00595	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000285	0.00555	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000284	0.00552	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000283	0.0055	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000276	0.00537	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000275	0.00535	CbGpPWpGaD
Hydralazine—CYP3A4—Liver X Receptor Pathway—ABCG5—coronary artery disease	0.000274	0.00532	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCD—coronary artery disease	0.000266	0.00517	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCD—coronary artery disease	0.000258	0.00501	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000256	0.00498	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000251	0.00488	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000245	0.00477	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000245	0.00477	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000239	0.00465	CbGpPWpGaD
Hydralazine—CYP3A4—Estrogen metabolism—SULT1E1—coronary artery disease	0.000228	0.00444	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000218	0.00423	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000218	0.00423	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—SULT1E1—coronary artery disease	0.000202	0.00393	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CREB1—coronary artery disease	0.000202	0.00392	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000201	0.0039	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000201	0.0039	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000201	0.0039	CbGpPWpGaD
Hydralazine—CYP3A4—blood—coronary artery disease	0.000201	0.00303	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000201	0.0039	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000196	0.0038	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—coronary artery disease	0.000176	0.00342	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—coronary artery disease	0.000174	0.00338	CbGpPWpGaD
Hydralazine—CYP3A4—Estrogen metabolism—SULT1A1—coronary artery disease	0.000171	0.00332	CbGpPWpGaD
Hydralazine—CYP3A4—Estrogen metabolism—GSTA1—coronary artery disease	0.000167	0.00325	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000155	0.00302	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000154	0.003	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—SULT1A1—coronary artery disease	0.000151	0.00294	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.00015	0.00292	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—coronary artery disease	0.00015	0.00291	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000149	0.00289	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000149	0.00289	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000148	0.00289	CbGpPWpGaD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—coronary artery disease	0.000148	0.00288	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000141	0.00274	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000131	0.00255	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000126	0.00245	CbGpPWpGaD
Hydralazine—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000121	0.00234	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000116	0.00225	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000111	0.00217	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000108	0.0021	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000108	0.0021	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000103	0.002	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.000103	0.002	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOB—coronary artery disease	9.85e-05	0.00191	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	9.46e-05	0.00184	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—coronary artery disease	8.76e-05	0.0017	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—coronary artery disease	8.71e-05	0.00169	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	8.62e-05	0.00168	CbGpPWpGaD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	8.42e-05	0.00164	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	8.28e-05	0.00161	CbGpPWpGaD
Hydralazine—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	8.15e-05	0.00159	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOA1—coronary artery disease	7.79e-05	0.00151	CbGpPWpGaD
Hydralazine—Pruritus—Simvastatin—coronary artery disease	7.7e-05	0.000556	CcSEcCtD
Hydralazine—Dizziness—Lovastatin—coronary artery disease	7.69e-05	0.000555	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Perindopril—coronary artery disease	7.65e-05	0.000552	CcSEcCtD
Hydralazine—Diarrhoea—Eplerenone—coronary artery disease	7.64e-05	0.000552	CcSEcCtD
Hydralazine—Muscle spasms—Lisinopril—coronary artery disease	7.61e-05	0.00055	CcSEcCtD
Hydralazine—Urticaria—Trandolapril—coronary artery disease	7.59e-05	0.000548	CcSEcCtD
Hydralazine—Constipation—Perindopril—coronary artery disease	7.58e-05	0.000547	CcSEcCtD
Hydralazine—Vomiting—Fenofibrate—coronary artery disease	7.58e-05	0.000547	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Losartan—coronary artery disease	7.57e-05	0.000547	CcSEcCtD
Hydralazine—Hypersensitivity—Valsartan—coronary artery disease	7.57e-05	0.000547	CcSEcCtD
Hydralazine—Urticaria—Enalapril—coronary artery disease	7.56e-05	0.000546	CcSEcCtD
Hydralazine—Body temperature increased—Trandolapril—coronary artery disease	7.55e-05	0.000545	CcSEcCtD
Hydralazine—Dizziness—Ezetimibe—coronary artery disease	7.55e-05	0.000545	CcSEcCtD
Hydralazine—Palpitations—Timolol—coronary artery disease	7.54e-05	0.000545	CcSEcCtD
Hydralazine—Body temperature increased—Enalapril—coronary artery disease	7.52e-05	0.000543	CcSEcCtD
Hydralazine—Feeling abnormal—Captopril—coronary artery disease	7.52e-05	0.000543	CcSEcCtD
Hydralazine—Rash—Fenofibrate—coronary artery disease	7.51e-05	0.000542	CcSEcCtD
Hydralazine—Dermatitis—Fenofibrate—coronary artery disease	7.51e-05	0.000542	CcSEcCtD
Hydralazine—Decreased appetite—Furosemide—coronary artery disease	7.49e-05	0.000541	CcSEcCtD
Hydralazine—Headache—Fenofibrate—coronary artery disease	7.46e-05	0.000539	CcSEcCtD
Hydralazine—Paraesthesia—Losartan—coronary artery disease	7.46e-05	0.000539	CcSEcCtD
Hydralazine—Urticaria—Telmisartan—coronary artery disease	7.46e-05	0.000538	CcSEcCtD
Hydralazine—Vomiting—Clopidogrel—coronary artery disease	7.45e-05	0.000538	CcSEcCtD
Hydralazine—Diarrhoea—Simvastatin—coronary artery disease	7.45e-05	0.000538	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Furosemide—coronary artery disease	7.44e-05	0.000537	CcSEcCtD
Hydralazine—Myalgia—Ramipril—coronary artery disease	7.43e-05	0.000537	CcSEcCtD
Hydralazine—Arthralgia—Ramipril—coronary artery disease	7.43e-05	0.000537	CcSEcCtD
Hydralazine—Tremor—Lisinopril—coronary artery disease	7.42e-05	0.000536	CcSEcCtD
Hydralazine—Body temperature increased—Telmisartan—coronary artery disease	7.42e-05	0.000536	CcSEcCtD
Hydralazine—Dyspnoea—Losartan—coronary artery disease	7.41e-05	0.000535	CcSEcCtD
Hydralazine—Anxiety—Ramipril—coronary artery disease	7.41e-05	0.000535	CcSEcCtD
Hydralazine—Vomiting—Lovastatin—coronary artery disease	7.4e-05	0.000534	CcSEcCtD
Hydralazine—Dizziness—Eplerenone—coronary artery disease	7.39e-05	0.000533	CcSEcCtD
Hydralazine—Rash—Clopidogrel—coronary artery disease	7.38e-05	0.000533	CcSEcCtD
Hydralazine—Dermatitis—Clopidogrel—coronary artery disease	7.38e-05	0.000533	CcSEcCtD
Hydralazine—Constipation—Furosemide—coronary artery disease	7.37e-05	0.000532	CcSEcCtD
Hydralazine—Hypersensitivity—Niacin—coronary artery disease	7.36e-05	0.000531	CcSEcCtD
Hydralazine—Ill-defined disorder—Lisinopril—coronary artery disease	7.35e-05	0.00053	CcSEcCtD
Hydralazine—Discomfort—Ramipril—coronary artery disease	7.34e-05	0.00053	CcSEcCtD
Hydralazine—Headache—Clopidogrel—coronary artery disease	7.34e-05	0.00053	CcSEcCtD
Hydralazine—Rash—Lovastatin—coronary artery disease	7.34e-05	0.00053	CcSEcCtD
Hydralazine—Dermatitis—Lovastatin—coronary artery disease	7.33e-05	0.000529	CcSEcCtD
Hydralazine—Anaemia—Lisinopril—coronary artery disease	7.32e-05	0.000528	CcSEcCtD
Hydralazine—Dyspepsia—Losartan—coronary artery disease	7.32e-05	0.000528	CcSEcCtD
Hydralazine—Feeling abnormal—Perindopril—coronary artery disease	7.3e-05	0.000527	CcSEcCtD
Hydralazine—Headache—Lovastatin—coronary artery disease	7.29e-05	0.000526	CcSEcCtD
Hydralazine—Pruritus—Valsartan—coronary artery disease	7.27e-05	0.000525	CcSEcCtD
Hydralazine—Myalgia—Timolol—coronary artery disease	7.27e-05	0.000525	CcSEcCtD
Hydralazine—Arthralgia—Timolol—coronary artery disease	7.27e-05	0.000525	CcSEcCtD
Hydralazine—Vomiting—Ezetimibe—coronary artery disease	7.26e-05	0.000524	CcSEcCtD
Hydralazine—Hypersensitivity—Pravastatin—coronary artery disease	7.25e-05	0.000523	CcSEcCtD
Hydralazine—Anxiety—Timolol—coronary artery disease	7.24e-05	0.000523	CcSEcCtD
Hydralazine—Pruritus—Olmesartan—coronary artery disease	7.24e-05	0.000522	CcSEcCtD
Hydralazine—Decreased appetite—Losartan—coronary artery disease	7.22e-05	0.000522	CcSEcCtD
Hydralazine—Body temperature increased—Captopril—coronary artery disease	7.21e-05	0.000521	CcSEcCtD
Hydralazine—Dizziness—Simvastatin—coronary artery disease	7.2e-05	0.00052	CcSEcCtD
Hydralazine—Rash—Ezetimibe—coronary artery disease	7.19e-05	0.000519	CcSEcCtD
Hydralazine—Dermatitis—Ezetimibe—coronary artery disease	7.19e-05	0.000519	CcSEcCtD
Hydralazine—Discomfort—Timolol—coronary artery disease	7.18e-05	0.000518	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	7.18e-05	0.0014	CbGpPWpGaD
Hydralazine—Headache—Ezetimibe—coronary artery disease	7.15e-05	0.000516	CcSEcCtD
Hydralazine—Malaise—Lisinopril—coronary artery disease	7.14e-05	0.000516	CcSEcCtD
Hydralazine—Oedema—Ramipril—coronary artery disease	7.13e-05	0.000515	CcSEcCtD
Hydralazine—Constipation—Losartan—coronary artery disease	7.11e-05	0.000513	CcSEcCtD
Hydralazine—Vomiting—Eplerenone—coronary artery disease	7.1e-05	0.000513	CcSEcCtD
Hydralazine—Feeling abnormal—Furosemide—coronary artery disease	7.1e-05	0.000512	CcSEcCtD
Hydralazine—Leukopenia—Lisinopril—coronary artery disease	7.09e-05	0.000512	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	7.08e-05	0.00138	CbGpPWpGaD
Hydralazine—Nausea—Fenofibrate—coronary artery disease	7.08e-05	0.000511	CcSEcCtD
Hydralazine—Pruritus—Niacin—coronary artery disease	7.07e-05	0.00051	CcSEcCtD
Hydralazine—Rash—Eplerenone—coronary artery disease	7.04e-05	0.000508	CcSEcCtD
Hydralazine—Urticaria—Perindopril—coronary artery disease	7.04e-05	0.000508	CcSEcCtD
Hydralazine—Hypersensitivity—Trandolapril—coronary artery disease	7.04e-05	0.000508	CcSEcCtD
Hydralazine—Dermatitis—Eplerenone—coronary artery disease	7.04e-05	0.000508	CcSEcCtD
Hydralazine—Diarrhoea—Valsartan—coronary artery disease	7.03e-05	0.000508	CcSEcCtD
Hydralazine—Hypersensitivity—Enalapril—coronary artery disease	7.01e-05	0.000506	CcSEcCtD
Hydralazine—Body temperature increased—Perindopril—coronary artery disease	7e-05	0.000506	CcSEcCtD
Hydralazine—Palpitations—Lisinopril—coronary artery disease	7e-05	0.000505	CcSEcCtD
Hydralazine—Diarrhoea—Olmesartan—coronary artery disease	7e-05	0.000505	CcSEcCtD
Hydralazine—Headache—Eplerenone—coronary artery disease	7e-05	0.000505	CcSEcCtD
Hydralazine—Thrombocytopenia—Ramipril—coronary artery disease	6.98e-05	0.000504	CcSEcCtD
Hydralazine—Oedema—Timolol—coronary artery disease	6.97e-05	0.000503	CcSEcCtD
Hydralazine—Pruritus—Pravastatin—coronary artery disease	6.96e-05	0.000503	CcSEcCtD
Hydralazine—Nausea—Clopidogrel—coronary artery disease	6.96e-05	0.000502	CcSEcCtD
Hydralazine—Tachycardia—Ramipril—coronary artery disease	6.96e-05	0.000502	CcSEcCtD
Hydralazine—Vomiting—Simvastatin—coronary artery disease	6.92e-05	0.0005	CcSEcCtD
Hydralazine—Hypersensitivity—Telmisartan—coronary artery disease	6.91e-05	0.000499	CcSEcCtD
Hydralazine—Nausea—Lovastatin—coronary artery disease	6.91e-05	0.000499	CcSEcCtD
Hydralazine—Rash—Simvastatin—coronary artery disease	6.86e-05	0.000495	CcSEcCtD
Hydralazine—Dermatitis—Simvastatin—coronary artery disease	6.85e-05	0.000495	CcSEcCtD
Hydralazine—Feeling abnormal—Losartan—coronary artery disease	6.85e-05	0.000494	CcSEcCtD
Hydralazine—Urticaria—Furosemide—coronary artery disease	6.84e-05	0.000494	CcSEcCtD
Hydralazine—Diarrhoea—Niacin—coronary artery disease	6.84e-05	0.000494	CcSEcCtD
Hydralazine—Headache—Simvastatin—coronary artery disease	6.82e-05	0.000492	CcSEcCtD
Hydralazine—Body temperature increased—Furosemide—coronary artery disease	6.81e-05	0.000492	CcSEcCtD
Hydralazine—Dizziness—Valsartan—coronary artery disease	6.8e-05	0.000491	CcSEcCtD
Hydralazine—Anorexia—Ramipril—coronary artery disease	6.79e-05	0.00049	CcSEcCtD
Hydralazine—Nausea—Ezetimibe—coronary artery disease	6.78e-05	0.000489	CcSEcCtD
Hydralazine—Dizziness—Olmesartan—coronary artery disease	6.76e-05	0.000488	CcSEcCtD
Hydralazine—Pruritus—Trandolapril—coronary artery disease	6.76e-05	0.000488	CcSEcCtD
Hydralazine—Myalgia—Lisinopril—coronary artery disease	6.74e-05	0.000487	CcSEcCtD
Hydralazine—Arthralgia—Lisinopril—coronary artery disease	6.74e-05	0.000487	CcSEcCtD
Hydralazine—Pruritus—Enalapril—coronary artery disease	6.73e-05	0.000486	CcSEcCtD
Hydralazine—Diarrhoea—Pravastatin—coronary artery disease	6.73e-05	0.000486	CcSEcCtD
Hydralazine—Anxiety—Lisinopril—coronary artery disease	6.72e-05	0.000485	CcSEcCtD
Hydralazine—Discomfort—Lisinopril—coronary artery disease	6.66e-05	0.000481	CcSEcCtD
Hydralazine—Hypotension—Ramipril—coronary artery disease	6.66e-05	0.000481	CcSEcCtD
Hydralazine—Anorexia—Timolol—coronary artery disease	6.64e-05	0.000479	CcSEcCtD
Hydralazine—Pruritus—Telmisartan—coronary artery disease	6.64e-05	0.000479	CcSEcCtD
Hydralazine—Nausea—Eplerenone—coronary artery disease	6.63e-05	0.000479	CcSEcCtD
Hydralazine—Dizziness—Niacin—coronary artery disease	6.61e-05	0.000477	CcSEcCtD
Hydralazine—Urticaria—Losartan—coronary artery disease	6.6e-05	0.000477	CcSEcCtD
Hydralazine—Body temperature increased—Losartan—coronary artery disease	6.57e-05	0.000474	CcSEcCtD
Hydralazine—Diarrhoea—Trandolapril—coronary artery disease	6.54e-05	0.000472	CcSEcCtD
Hydralazine—Vomiting—Valsartan—coronary artery disease	6.53e-05	0.000472	CcSEcCtD
Hydralazine—Diarrhoea—Enalapril—coronary artery disease	6.51e-05	0.00047	CcSEcCtD
Hydralazine—Hypotension—Timolol—coronary artery disease	6.51e-05	0.00047	CcSEcCtD
Hydralazine—Dizziness—Pravastatin—coronary artery disease	6.51e-05	0.00047	CcSEcCtD
Hydralazine—Vomiting—Olmesartan—coronary artery disease	6.5e-05	0.000469	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.49e-05	0.000469	CcSEcCtD
Hydralazine—Rash—Valsartan—coronary artery disease	6.48e-05	0.000468	CcSEcCtD
Hydralazine—Dermatitis—Valsartan—coronary artery disease	6.47e-05	0.000467	CcSEcCtD
Hydralazine—Nausea—Simvastatin—coronary artery disease	6.46e-05	0.000467	CcSEcCtD
Hydralazine—Oedema—Lisinopril—coronary artery disease	6.46e-05	0.000467	CcSEcCtD
Hydralazine—Pruritus—Captopril—coronary artery disease	6.46e-05	0.000466	CcSEcCtD
Hydralazine—Rash—Olmesartan—coronary artery disease	6.45e-05	0.000466	CcSEcCtD
Hydralazine—Dermatitis—Olmesartan—coronary artery disease	6.44e-05	0.000465	CcSEcCtD
Hydralazine—Headache—Valsartan—coronary artery disease	6.44e-05	0.000465	CcSEcCtD
Hydralazine—Diarrhoea—Telmisartan—coronary artery disease	6.42e-05	0.000464	CcSEcCtD
Hydralazine—Headache—Olmesartan—coronary artery disease	6.41e-05	0.000463	CcSEcCtD
Hydralazine—Paraesthesia—Ramipril—coronary artery disease	6.4e-05	0.000462	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	6.35e-05	0.00124	CbGpPWpGaD
Hydralazine—Dyspnoea—Ramipril—coronary artery disease	6.35e-05	0.000459	CcSEcCtD
Hydralazine—Vomiting—Niacin—coronary artery disease	6.35e-05	0.000459	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Timolol—coronary artery disease	6.35e-05	0.000458	CcSEcCtD
Hydralazine—Hypersensitivity—Furosemide—coronary artery disease	6.35e-05	0.000458	CcSEcCtD
Hydralazine—Thrombocytopenia—Lisinopril—coronary artery disease	6.33e-05	0.000457	CcSEcCtD
Hydralazine—Dizziness—Trandolapril—coronary artery disease	6.32e-05	0.000456	CcSEcCtD
Hydralazine—Tachycardia—Lisinopril—coronary artery disease	6.31e-05	0.000455	CcSEcCtD
Hydralazine—Rash—Niacin—coronary artery disease	6.3e-05	0.000455	CcSEcCtD
Hydralazine—Dermatitis—Niacin—coronary artery disease	6.29e-05	0.000454	CcSEcCtD
Hydralazine—Dizziness—Enalapril—coronary artery disease	6.29e-05	0.000454	CcSEcCtD
Hydralazine—Dyspepsia—Ramipril—coronary artery disease	6.27e-05	0.000453	CcSEcCtD
Hydralazine—Pruritus—Perindopril—coronary artery disease	6.27e-05	0.000453	CcSEcCtD
Hydralazine—Headache—Niacin—coronary artery disease	6.26e-05	0.000452	CcSEcCtD
Hydralazine—Paraesthesia—Timolol—coronary artery disease	6.26e-05	0.000452	CcSEcCtD
Hydralazine—Vomiting—Pravastatin—coronary artery disease	6.26e-05	0.000452	CcSEcCtD
Hydralazine—Diarrhoea—Captopril—coronary artery disease	6.24e-05	0.000451	CcSEcCtD
Hydralazine—Dyspnoea—Timolol—coronary artery disease	6.21e-05	0.000448	CcSEcCtD
Hydralazine—Dizziness—Telmisartan—coronary artery disease	6.21e-05	0.000448	CcSEcCtD
Hydralazine—Rash—Pravastatin—coronary artery disease	6.2e-05	0.000448	CcSEcCtD
Hydralazine—Dermatitis—Pravastatin—coronary artery disease	6.2e-05	0.000447	CcSEcCtD
Hydralazine—Decreased appetite—Ramipril—coronary artery disease	6.2e-05	0.000447	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—coronary artery disease	6.17e-05	0.0012	CbGpPWpGaD
Hydralazine—Headache—Pravastatin—coronary artery disease	6.16e-05	0.000445	CcSEcCtD
Hydralazine—Anorexia—Lisinopril—coronary artery disease	6.16e-05	0.000445	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Ramipril—coronary artery disease	6.15e-05	0.000444	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	6.13e-05	0.00119	CbGpPWpGaD
Hydralazine—Dyspepsia—Timolol—coronary artery disease	6.13e-05	0.000443	CcSEcCtD
Hydralazine—Hypersensitivity—Losartan—coronary artery disease	6.12e-05	0.000442	CcSEcCtD
Hydralazine—Nausea—Valsartan—coronary artery disease	6.1e-05	0.000441	CcSEcCtD
Hydralazine—Pruritus—Furosemide—coronary artery disease	6.09e-05	0.00044	CcSEcCtD
Hydralazine—Constipation—Ramipril—coronary artery disease	6.09e-05	0.00044	CcSEcCtD
Hydralazine—Nausea—Olmesartan—coronary artery disease	6.07e-05	0.000439	CcSEcCtD
Hydralazine—Vomiting—Trandolapril—coronary artery disease	6.07e-05	0.000439	CcSEcCtD
Hydralazine—Diarrhoea—Perindopril—coronary artery disease	6.06e-05	0.000438	CcSEcCtD
Hydralazine—Decreased appetite—Timolol—coronary artery disease	6.06e-05	0.000437	CcSEcCtD
Hydralazine—Vomiting—Enalapril—coronary artery disease	6.05e-05	0.000437	CcSEcCtD
Hydralazine—Hypotension—Lisinopril—coronary artery disease	6.04e-05	0.000436	CcSEcCtD
Hydralazine—Dizziness—Captopril—coronary artery disease	6.03e-05	0.000436	CcSEcCtD
Hydralazine—Rash—Trandolapril—coronary artery disease	6.02e-05	0.000435	CcSEcCtD
Hydralazine—Dermatitis—Trandolapril—coronary artery disease	6.02e-05	0.000434	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Timolol—coronary artery disease	6.01e-05	0.000434	CcSEcCtD
Hydralazine—Rash—Enalapril—coronary artery disease	6e-05	0.000433	CcSEcCtD
Hydralazine—Dermatitis—Enalapril—coronary artery disease	5.99e-05	0.000433	CcSEcCtD
Hydralazine—Headache—Trandolapril—coronary artery disease	5.99e-05	0.000432	CcSEcCtD
Hydralazine—Vomiting—Telmisartan—coronary artery disease	5.97e-05	0.000431	CcSEcCtD
Hydralazine—Headache—Enalapril—coronary artery disease	5.96e-05	0.00043	CcSEcCtD
Hydralazine—Nausea—Niacin—coronary artery disease	5.94e-05	0.000428	CcSEcCtD
Hydralazine—Rash—Telmisartan—coronary artery disease	5.92e-05	0.000427	CcSEcCtD
Hydralazine—Dermatitis—Telmisartan—coronary artery disease	5.91e-05	0.000427	CcSEcCtD
Hydralazine—Diarrhoea—Furosemide—coronary artery disease	5.89e-05	0.000426	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.89e-05	0.000425	CcSEcCtD
Hydralazine—Pruritus—Losartan—coronary artery disease	5.88e-05	0.000425	CcSEcCtD
Hydralazine—Headache—Telmisartan—coronary artery disease	5.88e-05	0.000424	CcSEcCtD
Hydralazine—Feeling abnormal—Ramipril—coronary artery disease	5.87e-05	0.000424	CcSEcCtD
Hydralazine—Dizziness—Perindopril—coronary artery disease	5.86e-05	0.000423	CcSEcCtD
Hydralazine—Nausea—Pravastatin—coronary artery disease	5.84e-05	0.000422	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	5.82e-05	0.00113	CbGpPWpGaD
Hydralazine—Paraesthesia—Lisinopril—coronary artery disease	5.8e-05	0.000419	CcSEcCtD
Hydralazine—Vomiting—Captopril—coronary artery disease	5.8e-05	0.000419	CcSEcCtD
Hydralazine—Dyspnoea—Lisinopril—coronary artery disease	5.76e-05	0.000416	CcSEcCtD
Hydralazine—Rash—Captopril—coronary artery disease	5.75e-05	0.000415	CcSEcCtD
Hydralazine—Dermatitis—Captopril—coronary artery disease	5.75e-05	0.000415	CcSEcCtD
Hydralazine—Feeling abnormal—Timolol—coronary artery disease	5.74e-05	0.000414	CcSEcCtD
Hydralazine—Headache—Captopril—coronary artery disease	5.72e-05	0.000413	CcSEcCtD
Hydralazine—Dizziness—Furosemide—coronary artery disease	5.7e-05	0.000411	CcSEcCtD
Hydralazine—Dyspepsia—Lisinopril—coronary artery disease	5.69e-05	0.000411	CcSEcCtD
Hydralazine—Diarrhoea—Losartan—coronary artery disease	5.69e-05	0.000411	CcSEcCtD
Hydralazine—Nausea—Trandolapril—coronary artery disease	5.67e-05	0.00041	CcSEcCtD
Hydralazine—Urticaria—Ramipril—coronary artery disease	5.66e-05	0.000409	CcSEcCtD
Hydralazine—Nausea—Enalapril—coronary artery disease	5.65e-05	0.000408	CcSEcCtD
Hydralazine—Vomiting—Perindopril—coronary artery disease	5.63e-05	0.000407	CcSEcCtD
Hydralazine—Body temperature increased—Ramipril—coronary artery disease	5.63e-05	0.000407	CcSEcCtD
Hydralazine—Decreased appetite—Lisinopril—coronary artery disease	5.62e-05	0.000406	CcSEcCtD
Hydralazine—Rash—Perindopril—coronary artery disease	5.59e-05	0.000403	CcSEcCtD
Hydralazine—Dermatitis—Perindopril—coronary artery disease	5.58e-05	0.000403	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.58e-05	0.000403	CcSEcCtD
Hydralazine—Nausea—Telmisartan—coronary artery disease	5.57e-05	0.000402	CcSEcCtD
Hydralazine—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	5.56e-05	0.00108	CbGpPWpGaD
Hydralazine—Headache—Perindopril—coronary artery disease	5.55e-05	0.000401	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	5.55e-05	0.00108	CbGpPWpGaD
Hydralazine—Urticaria—Timolol—coronary artery disease	5.53e-05	0.0004	CcSEcCtD
Hydralazine—Constipation—Lisinopril—coronary artery disease	5.53e-05	0.000399	CcSEcCtD
Hydralazine—Body temperature increased—Timolol—coronary artery disease	5.51e-05	0.000398	CcSEcCtD
Hydralazine—Dizziness—Losartan—coronary artery disease	5.5e-05	0.000397	CcSEcCtD
Hydralazine—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	5.48e-05	0.00107	CbGpPWpGaD
Hydralazine—Vomiting—Furosemide—coronary artery disease	5.48e-05	0.000395	CcSEcCtD
Hydralazine—Rash—Furosemide—coronary artery disease	5.43e-05	0.000392	CcSEcCtD
Hydralazine—Dermatitis—Furosemide—coronary artery disease	5.43e-05	0.000392	CcSEcCtD
Hydralazine—Nausea—Captopril—coronary artery disease	5.42e-05	0.000391	CcSEcCtD
Hydralazine—Headache—Furosemide—coronary artery disease	5.4e-05	0.00039	CcSEcCtD
Hydralazine—Feeling abnormal—Lisinopril—coronary artery disease	5.33e-05	0.000385	CcSEcCtD
Hydralazine—Vomiting—Losartan—coronary artery disease	5.28e-05	0.000382	CcSEcCtD
Hydralazine—Nausea—Perindopril—coronary artery disease	5.26e-05	0.00038	CcSEcCtD
Hydralazine—Hypersensitivity—Ramipril—coronary artery disease	5.25e-05	0.000379	CcSEcCtD
Hydralazine—Rash—Losartan—coronary artery disease	5.24e-05	0.000378	CcSEcCtD
Hydralazine—Dermatitis—Losartan—coronary artery disease	5.24e-05	0.000378	CcSEcCtD
Hydralazine—Headache—Losartan—coronary artery disease	5.21e-05	0.000376	CcSEcCtD
Hydralazine—Urticaria—Lisinopril—coronary artery disease	5.13e-05	0.000371	CcSEcCtD
Hydralazine—Hypersensitivity—Timolol—coronary artery disease	5.13e-05	0.000371	CcSEcCtD
Hydralazine—Nausea—Furosemide—coronary artery disease	5.12e-05	0.000369	CcSEcCtD
Hydralazine—Body temperature increased—Lisinopril—coronary artery disease	5.11e-05	0.000369	CcSEcCtD
Hydralazine—Pruritus—Ramipril—coronary artery disease	5.04e-05	0.000364	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	5.01e-05	0.000973	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	4.94e-05	0.000961	CbGpPWpGaD
Hydralazine—Nausea—Losartan—coronary artery disease	4.94e-05	0.000356	CcSEcCtD
Hydralazine—Pruritus—Timolol—coronary artery disease	4.93e-05	0.000356	CcSEcCtD
Hydralazine—Diarrhoea—Ramipril—coronary artery disease	4.88e-05	0.000352	CcSEcCtD
Hydralazine—Diarrhoea—Timolol—coronary artery disease	4.77e-05	0.000344	CcSEcCtD
Hydralazine—Hypersensitivity—Lisinopril—coronary artery disease	4.76e-05	0.000344	CcSEcCtD
Hydralazine—Dizziness—Ramipril—coronary artery disease	4.71e-05	0.00034	CcSEcCtD
Hydralazine—Dizziness—Timolol—coronary artery disease	4.61e-05	0.000333	CcSEcCtD
Hydralazine—Pruritus—Lisinopril—coronary artery disease	4.57e-05	0.00033	CcSEcCtD
Hydralazine—Vomiting—Ramipril—coronary artery disease	4.53e-05	0.000327	CcSEcCtD
Hydralazine—Rash—Ramipril—coronary artery disease	4.49e-05	0.000324	CcSEcCtD
Hydralazine—Dermatitis—Ramipril—coronary artery disease	4.49e-05	0.000324	CcSEcCtD
Hydralazine—Headache—Ramipril—coronary artery disease	4.46e-05	0.000322	CcSEcCtD
Hydralazine—Vomiting—Timolol—coronary artery disease	4.43e-05	0.00032	CcSEcCtD
Hydralazine—Diarrhoea—Lisinopril—coronary artery disease	4.42e-05	0.000319	CcSEcCtD
Hydralazine—Rash—Timolol—coronary artery disease	4.39e-05	0.000317	CcSEcCtD
Hydralazine—Dermatitis—Timolol—coronary artery disease	4.39e-05	0.000317	CcSEcCtD
Hydralazine—Headache—Timolol—coronary artery disease	4.36e-05	0.000315	CcSEcCtD
Hydralazine—Dizziness—Lisinopril—coronary artery disease	4.27e-05	0.000309	CcSEcCtD
Hydralazine—Nausea—Ramipril—coronary artery disease	4.23e-05	0.000306	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	4.16e-05	0.00081	CbGpPWpGaD
Hydralazine—Nausea—Timolol—coronary artery disease	4.14e-05	0.000299	CcSEcCtD
Hydralazine—Vomiting—Lisinopril—coronary artery disease	4.11e-05	0.000297	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	4.08e-05	0.000793	CbGpPWpGaD
Hydralazine—Rash—Lisinopril—coronary artery disease	4.08e-05	0.000294	CcSEcCtD
Hydralazine—Dermatitis—Lisinopril—coronary artery disease	4.07e-05	0.000294	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	4.06e-05	0.000789	CbGpPWpGaD
Hydralazine—Headache—Lisinopril—coronary artery disease	4.05e-05	0.000292	CcSEcCtD
Hydralazine—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	3.96e-05	0.00077	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	3.91e-05	0.000759	CbGpPWpGaD
Hydralazine—Nausea—Lisinopril—coronary artery disease	3.84e-05	0.000277	CcSEcCtD
Hydralazine—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	3.75e-05	0.00073	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	3.7e-05	0.00072	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	3.53e-05	0.000687	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	3.51e-05	0.000683	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GCLM—coronary artery disease	3.19e-05	0.000621	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	3.09e-05	0.000601	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	3.05e-05	0.000593	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	2.81e-05	0.000546	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	2.81e-05	0.000545	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	2.77e-05	0.000539	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	2.77e-05	0.000539	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	2.74e-05	0.000534	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	2.28e-05	0.000442	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	2.21e-05	0.00043	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	2.2e-05	0.000428	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	2.16e-05	0.000419	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	2.13e-05	0.000413	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	2.1e-05	0.000409	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GCLC—coronary artery disease	2.08e-05	0.000404	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	1.78e-05	0.000347	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GGT1—coronary artery disease	1.62e-05	0.000316	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA5B—coronary artery disease	1.47e-05	0.000287	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	1.46e-05	0.000284	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	1.44e-05	0.00028	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	1.34e-05	0.000261	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	1.32e-05	0.000257	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CKMT1B—coronary artery disease	1.25e-05	0.000244	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPAP2B—coronary artery disease	1.02e-05	0.000199	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	1.02e-05	0.000199	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CKM—coronary artery disease	1.02e-05	0.000199	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CKMT2—coronary artery disease	9.5e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PYGM—coronary artery disease	9.5e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SULT4A1—coronary artery disease	9.5e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	9.5e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PDK4—coronary artery disease	9.5e-06	0.000185	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—POMC—coronary artery disease	9.47e-06	0.000184	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GK—coronary artery disease	8.47e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PFKM—coronary artery disease	8.47e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMGCS2—coronary artery disease	8.47e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GYG1—coronary artery disease	8.47e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LDHA—coronary artery disease	8.47e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GATM—coronary artery disease	8.47e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AK1—coronary artery disease	8.08e-06	0.000157	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCH1—coronary artery disease	8.08e-06	0.000157	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MDH2—coronary artery disease	7.75e-06	0.000151	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UGCG—coronary artery disease	7.75e-06	0.000151	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLCD1—coronary artery disease	7.75e-06	0.000151	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPAT—coronary artery disease	7.75e-06	0.000151	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PGM1—coronary artery disease	7.46e-06	0.000145	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PYGB—coronary artery disease	7.2e-06	0.00014	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CKB—coronary artery disease	7.2e-06	0.00014	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DLAT—coronary artery disease	6.77e-06	0.000132	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTM2—coronary artery disease	6.77e-06	0.000132	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—COX5B—coronary artery disease	6.77e-06	0.000132	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLIN1—coronary artery disease	6.77e-06	0.000132	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	6.77e-06	0.000132	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	6.42e-06	0.000125	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	6.12e-06	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HK2—coronary artery disease	6.12e-06	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.87e-06	0.000114	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.76e-06	0.000112	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LCAT—coronary artery disease	5.76e-06	0.000112	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA4—coronary artery disease	5.65e-06	0.00011	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.46e-06	0.000106	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCLM—coronary artery disease	5.46e-06	0.000106	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.29e-06	0.000103	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.29e-06	0.000103	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.21e-06	0.000101	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HADH—coronary artery disease	5.13e-06	9.98e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.13e-06	9.98e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA2—coronary artery disease	4.86e-06	9.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX2—coronary artery disease	4.86e-06	9.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.86e-06	9.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HK1—coronary artery disease	4.81e-06	9.34e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.81e-06	9.34e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX4—coronary artery disease	4.81e-06	9.34e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.81e-06	9.34e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HADHA—coronary artery disease	4.75e-06	9.23e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.69e-06	9.13e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPA—coronary artery disease	4.64e-06	9.02e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.49e-06	8.74e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA5—coronary artery disease	4.45e-06	8.65e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—P4HB—coronary artery disease	4.36e-06	8.48e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.28e-06	8.33e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—VCAN—coronary artery disease	4.04e-06	7.85e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.01e-06	7.79e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DCN—coronary artery disease	3.89e-06	7.56e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.78e-06	7.36e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.69e-06	7.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.69e-06	7.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LIPC—coronary artery disease	3.69e-06	7.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HBA1—coronary artery disease	3.69e-06	7.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOC3—coronary artery disease	3.66e-06	7.12e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LDLR—coronary artery disease	3.64e-06	7.08e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.6e-06	7e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.6e-06	7e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCLC—coronary artery disease	3.56e-06	6.92e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CETP—coronary artery disease	3.56e-06	6.92e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SDC1—coronary artery disease	3.52e-06	6.84e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.32e-06	6.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.32e-06	6.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CTGF—coronary artery disease	3.25e-06	6.31e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.22e-06	6.25e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GOT2—coronary artery disease	3.22e-06	6.25e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.96e-06	5.75e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.87e-06	5.57e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GGT1—coronary artery disease	2.78e-06	5.4e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GOT1—coronary artery disease	2.78e-06	5.4e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.49e-06	4.85e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.47e-06	4.8e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.46e-06	4.78e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAT—coronary artery disease	2.43e-06	4.72e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOB—coronary artery disease	2.36e-06	4.58e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.29e-06	4.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPL—coronary artery disease	2.25e-06	4.37e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.19e-06	4.27e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CD36—coronary artery disease	2.14e-06	4.16e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.11e-06	4.1e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.03e-06	3.94e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGT—coronary artery disease	1.92e-06	3.74e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—coronary artery disease	1.89e-06	3.67e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.86e-06	3.62e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.64e-06	3.19e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—POMC—coronary artery disease	1.62e-06	3.15e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—coronary artery disease	1.48e-06	2.87e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.41e-06	2.75e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.29e-06	2.51e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.95e-07	1.55e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—coronary artery disease	6.49e-07	1.26e-05	CbGpPWpGaD
